| 2026-09-29 |
详情>>
内部人交易：
Zhang Jingjing Eason股份增加150600.00股
|
| 2026-09-29 |
详情>>
股本变动：
变动后总股本29693.43万股
|
| 2026-08-31 |
详情>>
业绩披露：
2026年中报每股收益0.79元,归母净利润9.62亿元,同比去年增长6.13%
|
| 2026-08-28 |
财报披露：
美东时间 2026-08-28 盘前发布财报
|
| 2026-05-27 |
详情>>
业绩披露：
2026年一季报每股收益1.03元,归母净利润12.51亿元,同比去年增长200.41%
|
| 2026-04-24 |
详情>>
业绩披露：
2025年年报每股收益0.98元,归母净利润12.05亿元,同比去年增长-53.96%
|
| 2025-11-20 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.10元,归母净利润13.47亿元,同比去年增长-25.68%
|
| 2025-08-21 |
详情>>
业绩披露：
2025年中报每股收益0.74元,归母净利润9.06亿元,同比去年增长-22.57%
|
| 2025-05-23 |
详情>>
业绩披露：
2025年一季报每股收益0.34元,归母净利润4.16亿元,同比去年增长-28.52%
|
| 2025-04-25 |
股东大会：
将于2025-06-12召开股东大会
会议内容 ▼▲
- 1.To receive and adopt the audited consolidated financial statements of the Company for the fiscal year ended December 31, 2024 and the reports of the directors and auditor thereon.
2.To authorise the board (the “Board”) of directors (the “Directors”) of the Company to fix the remuneration of the Directors.
3.To appoint Ernst & Young and Ernst & Young Hua Ming LLP as the auditors of the Company and authorise the Board to fix their remuneration for the year ending December 31, 2025.
4.To consider and, if thought fit, pass with or without modification the following resolutions as ordinary resolutions:
(A)“That:
(i)subject to paragraph (iii) below, pursuant to the Rules Governing the Listing of Securities (the “Listing Rules”) on The Stock Exchange of the Hong Kong Limited (the “Hong Kong Stock Exchange”), a general mandate be and is hereby generally and unconditionally given to the Directors during the Relevant Period (as defined hereinafter) to exercise all the powers of the Company to allot, issue and/or otherwise deal with additional shares of the Company (including any sale or transfer of treasury shares (which shall have the meaning ascribed to it under the Listing Rules) out of treasury) or securities convertible into shares, or options, warrants or similar rights to subscribe for shares or such convertible securities of the Company and to make or grant offers, agreements and/or options (including bonds, warrants and debentures convertible into shares of the Company);
(ii)the mandate in paragraph (i) above shall be in addition to any other authorisation given to the Directors and shall authorise the Directors during the Relevant Period (as defined hereinafter) to make or grant offers, agreements and/or options which may require the exercise of such powers after the end of the Relevant Period;
(iii)the aggregate number of shares allotted and issued or agreed conditionally or unconditionally to be allotted and issued (whether pursuant to options or otherwise) by the Directors during the Relevant Period (as defined hereinafter) pursuant to paragraph (i) above, otherwise than pursuant to:
(a)any Rights Issue (as defined hereinafter);
(b)the grant or exercise of any option under any share option scheme of the Company (if applicable) or any other option, scheme or similar arrangements for the time being adopted for the grant or issue to the Directors, officers and/or employees of the Company and/or any of its subsidiaries and/or other eligible participants specified thereunder of options to subscribe for shares or rights to acquire shares of the Company;
(c)the vesting of restricted shares and restricted share units granted or to be granted pursuant to the share incentive plan of the Company;
(d)any scrip dividend scheme or similar arrangement providing for the allotment and issue of shares in lieu of the whole or part of a dividend on shares of the Company in accordance with the articles of association of the Company;
(e)a specific authority granted by the shareholders of the Company in general meeting, shall not exceed 10% of the total number of issued shares of the Company (excluding any treasury shares) as at the date of the passing of this resolution (such total number to be subject to adjustment in the case of any consolidation or subdivision of any of the shares of the Company into a smaller or larger number of shares of the Company respectively after the passing of this resolution) and the said mandate shall be limited accordingly.
(iv)for the purpose of this resolution:
(a)“Relevant Period” means the period from the passing of this resolution until whichever is the earliest of:
(1)the conclusion of the next annual general meeting of the Company;
(2)the expiry of the period within which the next annual general meeting of the Company is required by any applicable laws or the articles of association of the Company to be held;
(3)the passing of an ordinary resolution by the shareholders of the Company in general meeting revoking or varying the authority given to the Directors by this resolution;
(b)“Rights Issue” means an offer of shares of the Company or an issue of warrants, options or other securities giving rights to subscribe for shares of the Company, open for a period fixed by the Directors to holders of shares of the Company on the register of members on a fixed record date in proportion to their then holdings of such shares of the Company (subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to fractional entitlements or, having regard to any restrictions or obligations under the laws of, or the requirements of, or the expense or delay which may be involved in determining the exercise or extent of any restrictions or obligations under the laws of, or the requirements of, any jurisdiction, any recognised regulatory body or any stock exchange applicable to the Company).”
(B)“That:
(i)subject to paragraph (ii) of this resolution, a general mandate be and is hereby generally and unconditionally given to the Directors during the Relevant Period (as defined hereinafter) to exercise all the powers of the Company to repurchase shares of the Company on the Hong Kong Stock Exchange or on any other stock exchange on which the shares of the Company may be listed and which is recognized for this purpose by the Securities and Futures Commission of Hong Kong and the Hong Kong Stock Exchange and, subject to and in accordance with all applicable laws, rules and regulations;
(ii)the aggregate number of shares to be repurchased pursuant to the mandate in paragraph (i) of this resolution shall not exceed 10% of the total number of issued shares of the Company (excluding any treasury shares) as at the date of passing this resolution, and if any subsequent consolidation or subdivision of shares is conducted, the maximum number of shares that may be repurchased under the mandate in paragraph (i) above as a percentage of the total number of issued shares at the date immediately before and after such consolidation and subdivision shall be the same, and the mandate shall be limited accordingly;
(iii)for the purpose of this resolution:
“Relevant Period” means the period from the passing of this resolution until whichever is the earliest of:
(a)the conclusion of the next annual general meeting of the Company;
(b)the expiry of the period within which the next annual general meeting of the Company is required by any applicable laws or the articles of association of the Company to be held;
(c)the passing of an ordinary resolution by the shareholders of the Company in general meeting revoking or varying the authority given to the Directors by this resolution.”
(C)“That conditional upon the resolutions numbered 4(A) and 4(B) set out in this notice being passed, the general mandate granted to the Directors to exercise the powers of the Company to allot, issue and/or otherwise deal with new shares of the Company (including any sale or transfer of treasury shares out of treasury) and to make or grant offers, agreements and/or options which might require the exercise of such powers pursuant to the resolution numbered 4(A) set out in this notice be and is hereby extended by the addition to the number of the issued shares of the Company which may be allotted and issued or agreed conditionally or unconditionally to be allotted and issued by the Directors pursuant to such general mandate of an amount representing the number of shares of the Company repurchased by the Company under the mandate granted pursuant to the resolution numbered 4(B) set out in this notice, provided that such extended amount shall not exceed 10% of the total number of issued shares of the Company (excluding any treasury shares) as at the date of passing of the said resolution.”
|
| 2025-04-24 |
详情>>
业绩披露：
2024年年报每股收益2.11元,归母净利润26.18亿元,同比去年增长16.17%
|
| 2025-03-24 |
详情>>
业绩披露：
2023年年报每股收益1.81元,归母净利润22.53亿元,同比去年增长253.08%
|
| 2024-12-02 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.46元,归母净利润18.12亿元,同比去年增长12.02%
|
| 2024-11-27 |
股东大会：
将于2025-01-17召开股东大会
会议内容 ▼▲
- 1.The Dairy Farm Share Purchase Agreement (as defined in the circular dated November 22, 2024 despatched to the shareholders of the Company (the “Circular”), a copy of which has been produced to the EGM marked “A” and signed by the chairman of the EGM for the purpose of identification) and the transactions contemplated thereunder be and are hereby approved, confirmed and ratified;
2.The Jingdong Share Purchase Agreement (as defined in the Circular, a copy of which has been produced to the EGM marked “B” and signed by the chairman of the EGM for the purpose of identification, together with the Dairy Farm Share Purchase Agreement, the “Share Purchase Agreements”), and the transactions contemplated thereunder be and are hereby approved, confirmed and ratified;
3.Any one of the directors of the Company be and is hereby authorized to do all such acts and things incidental to the Share Purchase Agreements as he/she considers necessary, desirable, or expedient in connection with the implementation of or giving effect to the Share Purchase Agreements and the transactions contemplated thereunder.
|
| 2024-05-23 |
股东大会：
将于2024-06-20召开股东大会
会议内容 ▼▲
- 1.To receive and adopt the audited consolidated financial statements of the Company for the six months ended December 31, 2023 and the reports of the directors and auditor thereon.
2.(A)To re-elect the following directors of the Company (the “Directors”):(i)To re-elect Mr. Ye Guofu as an executive Director;(ii) To re-elect Mr. Wang Yongping as an independent non-executive Director.(B)To authorise the board of Directors to fix the remuneration of the Directors.
3.To re-appoint KPMG as auditor of the Company and authorise the board of Directors to fix its remuneration for the year ending December 31, 2024.
4.To consider and, if thought fit, pass with or without modification the following resolutions as ordinary resolutions:(A)“That:(i)subject to paragraph (iii) below, pursuant to the Rules Governing the Listing of Securities (the “Listing Rules”) on The Stock Exchange of the Hong Kong Limited (the “Hong Kong Stock Exchange”), a general mandate be and is hereby generally and unconditionally given to the Directors during the Relevant Period (as defined hereinafter) to exercise all the powers of the Company to allot, issue and/or otherwise deal with additional shares of the Company (including any sale or transfer of treasury shares (which shall have the meaning ascribed to it under the Listing Rules coming into effect on June 11, 2024) out of treasury) or securities convertible into shares, or options, warrants or similar rights to subscribe for shares or such convertible securities of the Company and to make or grant offers, agreements and/or options (including bonds, warrants and debentures convertible into shares of the Company);(ii)the mandate in paragraph (i) above shall be in addition to any other authorisation given to the Directors and shall authorise the Directors during the Relevant Period (as defined hereinafter) to make or grant offers, agreements and/or options which may require the exercise of such powers after the end of the Relevant Period;(iii)the aggregate number of shares allotted and issued or agreed conditionally or unconditionally to be allotted and issued (whether pursuant to options or otherwise) by the Directors during the Relevant Period (as defined hereinafter) pursuant to paragraph (i) above, otherwise than pursuant to:(a)any Rights Issue (as defined hereinafter);(b)the grant or exercise of any option under any share option scheme of the Company (if applicable) or any other option, scheme or similar arrangements for the time being adopted for the grant or issue to the Directors, officers and/or employees of the Company and/or any of its subsidiaries and/or other eligible participants specified thereunder of options to subscribe for shares or rights to acquire shares of the Company;(c)the vesting of restricted shares and restricted share units granted or to be granted pursuant to the share incentive plan of the Company;(d)any scrip dividend scheme or similar arrangement providing for the allotment and issue of shares in lieu of the whole or part of a dividend on shares of the Company in accordance with the articles of association of the Company;(e)a specific authority granted by the shareholders of the Company in general meeting, shall not exceed 5% of the total number of issued Shares of the Company (excluding any treasury shares) as at the date of the passing of this resolution (such total number to be subject to adjustment in the case of any consolidation or subdivision of any of the shares of the Company into a smaller or larger number of shares of the Company respectively after the passing of this resolution) and the said mandate shall be limited accordingly.(iv)for the purpose of this resolution:(a)“Relevant Period” means the period from the passing of this resolution until whichever is the earliest of:(1)the conclusion of the next annual general meeting of the Company;(2)the expiry of the period within which the next annual general meeting of the Company is required by any applicable laws or the articles of association of the Company to be held;(3)the passing of an ordinary resolution by the shareholders of the Company in general meeting revoking or varying the authority given to the Directors by this resolution; and(b)“Rights Issue” means an offer of shares of the Company or an issue of warrants, options or other securities giving rights to subscribe for shares of the Company, open for a period fixed by the Directors to holders of shares of the Company on the register of members on a fixed record date in proportion to their then holdings of such shares of the Company (subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to fractional entitlements or, having regard to any restrictions or obligations under the laws of, or the requirements of, or the expense or delay which may be involved in determining the exercise or extent of any restrictions or obligations under the laws of, or the requirements of, any jurisdiction, any recognised regulatory body or any stock exchange applicable to the Company).”(B)“That:(i)subject to paragraph (ii) of this resolution, a general mandate be and is hereby generally and unconditionally given to the Directors during the Relevant Period (as defined hereinafter) to exercise all the powers of the Company to repurchase shares of the Company on the Hong Kong Stock Exchange or on any other stock exchange on which the shares of the Company may be listed and which is recognized for this purpose by the Securities and Futures Commission of Hong Kong and the Hong Kong Stock Exchange and, subject to and in accordance with all applicable laws, rules and regulations;(ii)the aggregate number of shares to be repurchased pursuant to the mandate in paragraph (i) of this resolution shall not exceed 10% of the total number of issued shares of the Company as at the date of passing this resolution, and if any subsequent consolidation or subdivision of shares is conducted, the maximum number of shares that may be repurchased under the mandate in paragraph (i) above as a percentage of the total number of issued shares at the date immediately before and after such consolidation and subdivision shall be the same, and the mandate shall be limited accordingly;(iii) for the purpose of this resolution:“Relevant Period” means the period from the passing of this resolution until whichever is the earliest of:(a)the conclusion of the next annual general meeting of the Company;(b)the expiry of the period within which the next annual general meeting of the Company is required by any applicable laws or the articles of association of the Company to be held;(c)the passing of an ordinary resolution by the shareholders of the Company in general meeting revoking or varying the authority given to the Directors by this resolution.”(C)“That conditional upon the resolutions numbered 4(A) and 4(B) set out in this notice being passed, the general mandate granted to the Directors to exercise the powers of the Company to allot, issue and/or otherwise deal with new shares of the Company (including any sale or transfer of treasury shares out of treasury) and to make or grant offers, agreements and/or options which might require the exercise of such powers pursuant to the resolution numbered 4(A) set out in this notice be and is hereby extended by the addition to the number of the issued shares of the Company which may be allotted and issued or agreed conditionally or unconditionally to be allotted and issued by the Directors pursuant to such general mandate of an amount representing the number of shares of the Company repurchased by the Company under the mandate granted pursuant to the resolution numbered 4(B) set out in this notice, provided that such extended amount shall not exceed 10% of the total number of issued shares of the Company (excluding any treasury Shares) as at the date of passing of the said resolution.”.
|
| 2023-10-19 |
股东大会：
将于2023-12-21召开股东大会
会议内容 ▼▲
- 1.To receive and adopt the audited consolidated financial statements of the Company for the year ended June 30, 2023 and the reports of the directors and auditor thereon.
2.(a)To re-elect the following directors of the Company (the “Directors”):(i)To re-elect Ms. Xu Lili as an independent non-executive Director;(ii)To re-elect Mr. Zhu Yonghua as an independent non-executive Director.(b)To authorise the board of Directors to fix the remuneration of the Directors.
3.To re-appoint KPMG as auditor of the Company and authorise the board of Directors to fix its remuneration for the year ending June 30, 2024.
4.To consider and, if thought fit, pass with or without modification the following resolutions as ordinary resolutions:(A)That:(i)subject to paragraph (iii) below, pursuant to the Rules Governing the Listing of Securities on The Stock Exchange of the Hong Kong Limited (the “Hong Kong Stock Exchange”), a general mandate be and is hereby generally and unconditionally given to the Directors during the Relevant Period (as defined hereinafter) to exercise all the powers of the Company to allot, issue and/or otherwise deal with additional shares of the Company or securities convertible into shares, or options, warrants or similar rights to subscribe for shares or such convertible securities of the Company and to make or grant offers, agreements and/or options (including bonds, warrants and debentures convertible into shares of the Company);(ii)the mandate in paragraph (i) above shall be in addition to any other authorisation given to the Directors and shall authorise the Directors during the Relevant Period (as defined hereinafter) to make or grant offers, agreements and/or options which may require the exercise of such powers after the end of the Relevant Period;(iii)the aggregate number of shares allotted and issued or agreed conditionally or unconditionally to be allotted and issued (whether pursuant to options or otherwise) by the Directors during the Relevant Period (as defined hereinafter) pursuant to paragraph (i) above, otherwise than pursuant to:(a)any Rights Issue (as defined hereinafter);(b)the grant or exercise of any option under any share option scheme of the Company (if applicable) or any other option, scheme or similar arrangements for the time being adopted for the grant or issue to the Directors, officers and/or employees of the Company and/or any of its subsidiaries and/or other eligible participants specified thereunder of options to subscribe for shares or rights to acquire shares of the Company;(c)the vesting of restricted shares and restricted share units granted or to be granted pursuant to the share incentive plan of the Company;(d)any scrip dividend scheme or similar arrangement providing for the allotment and issue of shares in lieu of the whole or part of a dividend on shares of the Company in accordance with the articles of association of the Company;(e)a specific authority granted by the shareholders of the Company in general meeting, shall not exceed 20% of the total number of issued Shares of the Company as at the date of the passing of this resolution (such total number to be subject to adjustment in the case of any consolidation or subdivision of any of the shares of the Company into a smaller or larger number of shares of the Company respectively after the passing of this resolution) and the said mandate shall be limited accordingly.(iv)for the purpose of this resolution:(a)“Relevant Period” means the period from the passing of this resolution until whichever is the earliest of:(1)the conclusion of the next annual general meeting of the Company;(2)the expiry of the period within which the next annual general meeting of the Company is required by any applicable laws or the articles of association of the Company to be held;(3)the passing of an ordinary resolution by the shareholders of the Company in general meeting revoking or varying the authority given to the Directors by this resolution;(b)“Rights Issue” means an offer of shares of the Company or an issue of warrants, options or other securities giving rights to subscribe for shares of the Company, open for a period fixed by the Directors to holders of shares of the Company on the register of members on a fixed record date in proportion to their then holdings of such shares of the Company (subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to fractional entitlements or, having regard to any restrictions or obligations under the laws of, or the requirements of, or the expense or delay which may be involved in determining the exercise or extent of any restrictions or obligations under the laws of, or the requirements of, any jurisdiction, any recognised regulatory body or any stock exchange applicable to the Company).”(B)That:(i)subject to paragraph (ii) of this resolution, a general mandate be and is hereby generally and unconditionally given to the Directors during the Relevant Period (as defined hereinafter) to exercise all the powers of the Company to repurchase shares of the Company on the Hong Kong Stock Exchange or on any other stock exchange on which the shares of the Company may be listed and which is recognized for this purpose by the Securities and Futures Commission of Hong Kong and the Hong Kong Stock Exchange and, subject to and in accordance with all applicable laws, rules and regulations;(ii)the aggregate number of shares to be repurchased pursuant to the mandate in paragraph (i) of this resolution shall not exceed 10% of the total number of issued shares of the Company as at the date of passing this resolution, and if any subsequent consolidation or subdivision of shares is conducted, the maximum number of shares that may be repurchased under the mandate in paragraph (i) above as a percentage of the total number of issued shares at the date immediately before and after such consolidation and subdivision shall be the same, and the mandate shall be limited accordingly;(iii) for the purpose of this resolution:“Relevant Period” means the period from the passing of this resolution until whichever is the earliest of:(a)the conclusion of the next annual general meeting of the Company;(b)the expiry of the period within which the next annual general meeting of the Company is required by any applicable laws or the articles of association of the Company to be held;(c)the passing of an ordinary resolution by the shareholders of the Company in general meeting revoking or varying the authority given to the Directors by this resolution.”(C)That conditional upon the resolutions numbered 4(A) and 4(B) set out in this notice being passed, the general mandate granted to the Directors to exercise the powers of the Company to allot, issue and/or otherwise deal with new shares of the Company and to make or grant offers, agreements and/or options which might require the exercise of such powers pursuant to the resolution numbered 4(A) set out in this notice be and is hereby extended by the addition to the number of the issued shares of the Company which may be allotted and issued or agreed conditionally or unconditionally to be allotted and issued by the Directors pursuant to such general mandate of an amount representing the number of shares of the Company repurchased by the Company under the mandate granted pursuant to the resolution numbered 4(B) set out in this notice, provided that such extended amount shall not exceed 10% of the total number of issued shares of the Company as at the date of passing of the said resolution.”
|
| 2022-10-19 |
股东大会：
将于2022-12-07召开股东大会
会议内容 ▼▲
- 1.To receive and adopt the audited consolidated financial statements of the Company for the year ended June 30, 2022 and the reports of the directors and auditor thereon.
2.(A)To re-elect the following directors of the Company (the “Directors”):(i)To re-elect Mr. Li Minxin as an executive Director;(ii)To re-elect Mr. Zhang Saiyin as an executive Director.
(B)To authorise the board of Directors to fix the remuneration of the Directors.
3.To re-appoint KPMG as auditor of the Company and authorise the board of Directors to fix its remuneration for the year ending June 30,2023.
|
| 2022-06-21 |
股东大会：
将于2022-07-11召开股东大会
会议内容 ▼▲
- 1.As a special resolution, that, conditional upon and with effect from the consummation of the company’s proposed listing on the stock exchange of hong kong limited (the "hk stock exchange"), the authorized share capital of the company be varied as follows (the “variation of share capital”):
a.All the authorized class a ordinary shares of a par value of us$0.00001 each (the “class a ordinary shares”) (whether issued or unissued), class b ordinary shares of a par value of us$0.00001 each (the “class b ordinary shares”) (whether issued or unissued) and shares of a par value of us$0.00001 each of such class or classes (however designated) as the directors of the company (the “directors”) may determine in accordance with article 9 of the second amended and restated memorandum and articles of association of the company (the “current m&aa”) (whether issued or unissued) in the authorized share capital of the company be, and hereby are, re-designated as ordinary shares of a par value of us$0.00001 each, such that following such re-designation, the authorized share capital of the company shall be us$100,000 divided into 10,000,000,000 ordinary shares of a par value of us$0.00001 each (the “ordinary shares”);
b.All of the issued and outstanding class a ordinary shares (including all class a ordinary shares converted from class b ordinary shares pursuant to a share conversion notice delivered by the holder of such class b ordinary shares addressed to the company) be and hereby are, re-classified and re-designated into ordinary shares on a one-for-one basis, all of which shall be duly authorized, validly issued, credited as fully paid and non-assessable;
c.All of the issued and outstanding options and other awards granted by the company pursuant to its share incentive plan(s) shall entitle the holders thereof to such number of ordinary shares equivalent to the same number of class a ordinary shares that the holders would be entitled to as originally set out in the relevant award agreement and the company shall issue such number of ordinary shares to the holders of such options or other awards granted pursuant to the share incentive plans upon vesting and exercise of such options or other awards by the holders;
d.The register of members of the company be updated to record the variation of share capital (including the re-designation of shares) as resolved above, and that new share certificates be issued to the holders thereof upon request, with full power and authority hereby granted to any one director to prepare, sign, seal and deliver any such share certificates;
e.The registered office provider of the company be authorized to attend to all necessary filings with the registrar of companies in the cayman islands in respect of the foregoing resolutions.
2.As a special resolution, that, conditional upon and with effect from the company’s proposed listing on the hk stock exchange, the current m&aa be amended and restated by the deletion in their entirety and by the substitution in their place of the third amended and restated memorandum of association and articles of association in the form as attached hereto as appendix i (the “amended m&aa”);
3.As an ordinary resolution, that:
a.Subject to paragraph (c) below, a general unconditional mandate be and is hereby given to the directors of the company during the relevant period (as defined in paragraph (d) below) to exercise all the powers of the company to allot, issue, and deal with additional ordinary shares or securities convertible into ordinary shares, or options, warrants or similar rights to subscribe for ordinary shares or such convertible securities of the company (other than issuance of options, warrants or similar rights to subscribe for additional ordinary shares or securities convertible into ordinary shares for cash consideration) and to make or grant offers, agreements, or options (including any warrants, bonds, notes, and debentures conferring any rights to subscribe for or otherwise receive ordinary shares) that would or might require the exercise of such powers;
b.The mandate in paragraph (a) above shall be in addition to any other authorization given to the directors and shall authorize the directors to make or grant offers, agreements and/or options during the relevant period that would or might require the exercise of such powers after the end of the relevant period;
c.The total number of ordinary shares allotted or agreed conditionally or unconditionally to be allotted and issued (whether pursuant to options or otherwise) in paragraph (a) above, otherwise than pursuant to:
(i)a rights issue (as defined in paragraph (d) below);
(ii)the grant or exercise of any options under any share option scheme of the company or any other option, scheme or similar arrangements for the time being adopted for the grant or issue to the directors, officers and/or employee of the company and/or any of its subsidiaries and/or other eligible participants specified thereunder
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|